/PRNewswire/ The Centers for Medicare & Medicaid Services (CMS) has finalized its decision to establish payment rates for PainTEQ s new Current Procedural.
/PRNewswire/ PainTEQ, a leading innovator in minimally invasive sacroiliac (SI) joint dysfunction treatments, announced the release of its new Surgery-Ready.
/PRNewswire/ PainTEQ, a market leader in minimally invasive posterior sacroiliac (SI) joint fusion procedures, today announced the closing of $35 million in.